3651 results for «550»

Filter By

3651 results

Large-bore venous access and vessel closure: all you need to know

19 May 2026 – From EuroPCR 2026

This session provides a comprehensive guide to large-bore venous access and vessel closure techniques, emphasizing best practices and the advantages of ultrasound-guided suture mediated vessel closure compared to traditional figure-of-eight suture methods. It also addresses strategies to avoid and manage potential complications encountered during these procedures.

Large-bore venous access and vessel closure: all you need to know

DCB in contemporary PCI: evidence, technique and physiology-guided decision-making

19 May 2026 – From EuroPCR 2026

This EuroPCR 2026 session explores the evolving role of drug-coated balloons (DCB) in contemporary PCI, highlighting how growing clinical evidence, refined procedural strategies and physiology-guided tools are reshaping everyday practice.

The discussion reviews the latest data supporting DCB use, including long-term outcomes from major registries and trials...

DCB in contemporary PCI: evidence, technique and physiology-guided decision-making

Evolving bifurcation treatment practices: DCB, angio-based FFR and side branch optimisation

19 May 2026 – From EuroPCR 2026

This EuroPCR 2026 session explores the evolving landscape of bifurcation PCI, focusing on drug-coated balloon (DCB) strategies, angio-based fractional flow reserve (FFR) and side branch optimisation. It highlights how new evidence and physiology-guided tools are reshaping decision-making in this complex lesion subset.

Discussions include insights from the...

Evolving bifurcation treatment practices: DCB, angio-based FFR and side branch optimisation

Interventional therapy for hypertension

19 May 2026 – From EuroPCR 2026

This session addresses interventional therapies for hypertension, emphasizing patient selection for renal denervation and integration of this technique within comprehensive hypertension management. It also reviews available renal denervation technologies, optimal procedural approaches, and considerations for interventional treatment of renal artery stenosis.

Interventional therapy for hypertension

CTO PCI: how to prevent and manage complications effectively?

19 May 2026 – From EuroPCR 2026

Focused on chronic total occlusion (CTO) PCI, this session highlights the critical importance of procedural planning to minimize complications. Through detailed case analyses of coronary dissection and perforation, it outlines early identification strategies and equips clinicians with essential tools and techniques for effective complication management in...

CTO PCI: how to prevent and manage complications effectively?

New evidence for pharmacology for coronary artery disease

19 May 2026 – From EuroPCR 2026

This session presents the latest evidence in pharmacological management of coronary artery disease, featuring pivotal trials such as VESALIUS-CV and TARGET FIRST. It covers topics including evolocumab efficacy post-stenting, early aspirin cessation strategies, aspirin-free protocols after complex PCI in ACS, and comparative outcomes of clopidogrel versus...

New evidence for pharmacology for coronary artery disease

The thin line between success and failure in MedTech start ups - Lessons learnt

18 May 2026 – From EuroPCR 2026

This session examines critical success factors for MedTech start-ups through real-world examples, discussing challenges, investment dynamics, and the pivotal role of the Chief Medical Officer and investor syndicates in fostering sustainable growth.

AI for clinical and academic cardiology knowledge work: innovation or academic misconduct ? Literature search, data extraction and responsible use

19 May 2026 – From EuroPCR 2026

This session critically examines the role of artificial intelligence in clinical and academic cardiology, focusing on its application in literature search, evidence synthesis, and report structuring. It discusses responsible AI use, emphasizing the balance between assistance and academic integrity, and features a debate on authorship, transparency,...

Artificial intelligence and advanced imaging in coronary interventions

19 May 2026 – From EuroPCR 2026

This session explores the integration of artificial intelligence with advanced imaging modalities in coronary interventions. Topics include quantitative myocardial blood flow assessment via co-registered CCTA and angiography, AI-guided real-time procedural support, novel video frame interpolation techniques, high-risk plaque identification through AI-derived OCT stress mapping, and validation...

Managing complex calcified PCI: pitfalls and complications

20 May 2026 – From EuroPCR 2026

This session addresses the complexities and challenges of performing PCI in heavily calcified coronary lesions. Emphasizing the critical role of imaging in procedural planning, it updates on contemporary tools and techniques to mitigate complications. The session also shares practical experience in managing common complications such as...

Managing complex calcified PCI: pitfalls and complications

Thrombectomy in pulmonary embolism

19 May 2026 – From EuroPCR 2026

This session addresses the critical role of mechanical thrombectomy in managing pulmonary embolism, focusing on rescue interventions in refractory massive acute cases. It explores clinical and technical challenges that extend beyond current guidelines, reviews complex cases including intermediate-high risk pulmonary embolism with peripheral embolism, intracardiac thrombosis,...

Thrombectomy in pulmonary embolism

Insight from recent evidence in structural heart disease: indications for LAA closure (CHAMPION) and PCI in TAVI candidates (PRO-TAVI)

20 May 2026 – From EuroPCR 2026

This session reviews recent evidence impacting the management of structural heart disease, focusing on left atrial appendage (LAA) closure indications and PCI considerations in transcatheter aortic valve implantation (TAVI) candidates. It discusses optimal strategies for coronary artery disease in TAVI patients and evaluates findings from the...

Insight from recent evidence in structural heart disease: indications for LAA closure (CHAMPION) and PCI in TAVI candidates (PRO-TAVI)

Rescue techniques for coronary interventions

20 May 2026 – From EuroPCR 2026

This session presents an array of advanced rescue techniques employed in coronary interventions when unexpected complications arise. It features real-world cases including management of complex coronary artery aneurysms, malignant pericardial tamponade, challenging primary PCI scenarios, and innovative bailout strategies such as self-made covered stents and guidewire...

Rescue techniques for

Back to the future - Lessons from the past that can guide contemporary practice

20 May 2026 – From EuroPCR 2026

Reflecting on historical perspectives in the management of atherosclerotic coronary vascular disease, this session imparts valuable lessons to guide contemporary PCI practice. It emphasizes best practices in vessel preparation, evaluates the significance of drug-eluting stents, and provides a pathologist’s insight into mechanisms of PCI failure to...

Back to the future - Lessons from the past that can guide contemporary practice

Innovative strategy in ACS

20 May 2026 – From EuroPCR 2026

Focusing on innovative strategies in acute coronary syndrome (ACS), this session reviews recent advances including drug-coated balloons in STEMI, early discharge safety guided by microcirculatory resistance indices, intravascular lithotripsy for coronary calcification in ACS, and novel stenting protocols demonstrated in randomized trials, providing a comprehensive update...

Innovative strategy in ACS

Debate: how will AI change the cardiology landscape in the next five years?

20 May 2026 – From EuroPCR 2026

Delve into the anticipated impact of artificial intelligence on cardiology over the next five years. This session addresses AI's role in reporting, triage, workflow optimization, and decision-making, while distinguishing realistic clinical benefits from hype. It also discusses governance, accountability, and legal considerations surrounding AI adoption in...

Structural heart devices: what's new and how it reaches your cathlab

20 May 2026 – From EuroPCR 2026

Discover the latest innovations in structural heart devices, spanning new TAVR platforms, mitral and tricuspid valve technologies, leaflet modification, and closure devices. Gain insight into the comprehensive innovation pathway from concept and prototyping to regulatory approval and clinical adoption, with perspectives from physician-innovators on drivers of...

AI in imaging & the cathlab - opportunities in procedural planning & guidance

20 May 2026 – From EuroPCR 2026

This session explores the role of artificial intelligence in imaging and the cathlab, emphasizing computer vision applications distinct from language models. It discusses AI's integration into procedural planning and guidance, balancing algorithmic support with physician judgement to enhance interventional cardiology workflows.

Coronary innovations and artificial intelligence: new devices, smarter tools, better outcomes

20 May 2026 – From EuroPCR 2026

This session provides a practical update on emerging coronary innovations and AI technologies, including next-generation calcium modification devices, bioresorbable scaffolds, sirolimus drug-coated balloons, and AI-driven coronary physiology and imaging tools. It offers a roadmap for integrating these advancements into clinical practice, addressing technology selection, reimbursement, training,...

Outcomes in tricuspid valve intervention

19 May 2026 – From EuroPCR 2026

This session reviews contemporary clinical outcomes of tricuspid valve interventions. Topics include interim results from the Cardiovalve replacement system trial, the impact of atrial fibrillation on tricuspid TEER, residual regurgitation implications, afterload mismatch post-intervention, and long-term bioprosthetic valve durability.

Outcomes in tricuspid valve intervention
Didn’t find what you were looking for?